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In a longitudinal, retrospective study, we monitored the level of heteroplasmy at nucleotide position (nt) 309 and
nt 16189 of the control region of human mtDNA. As a unique source of DNA, we analyzed multiple cervical-cell
samples collected, during 1 or 2 decades, from four women with heteroplasmy at either nt 309 or nt 16189.
According to accurate, quantitative analysis by solid-phase minisequencing, the level of heteroplasmy remained
stable in the cervical-cell samples from all four women during the time studied. We also analyzed autopsy samples
from several different tissues, all containing nt 309 in heteroplasmic form, of one of the women, who was deceased.
On the basis of our results, heteroplasmy in the control region of mtDNA seems to be inherited and is not the
result of somatic age-related accumulation.
Disease-causing mutations in mtDNA are typically het-
eroplasmic, with normal and mutant sequences coexist-
ing at variable levels in the same individual (Wallace
1999). Heteroplasmy at neutral polymorphic nucleotide
positions of human mtDNA has been observed only spo-
radically (Comas et al. 1995; Bendall et al. 1996; Ivanov
et al. 1996; Jazin et al. 1996; Parsons et al. 1997). Recent
studies have, however, suggested that heteroplasmy of
neutral mtDNA sequence variants may bemore common
than has been postulated (Calloway et al. 2000; Howell
and Smejkal 2000; Tully et al. 2000) and that the fre-
quency of heteroplasmic polymorphisms increases with
age, at least when studied either in cell cultures (Mi-
chikawa et al. 1999) or in population groups at different
ages (Calloway et al. 2000). To address this question in
vivo, we performed a longitudinal retrospective study in
which we monitored the fluctuation of heteroplasmy lev-
els of sequence variants in the human mtDNA control
region in the same four individuals during 1 or 2 decades
of life.
Cervical-cell samples that are collected every 3d year
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from Swedish women, to screen for cervical cancer,
served as a unique source of DNA for the study. Initially,
mtDNA in leukocytes from 36 women was screened for
heteroplasmy by solid-phase minisequencing (Syva¨nen
et al. 1993) at eight polymorphic nucleotide positions
(nt) reported, in previous studies (Bendall and Sykes
1995; Parsons et al. 1997), to occur in heteroplasmic
form. The eight analyzed polymorphic variants were
G185A, A189G, del309C, T16089C, C16092T,
T16093C, C16189T, and C16192T. PCR and mini-
sequencing primer sequences and reaction conditions
are available from the authors, on request. The mini-
sequencing method allows quantitative determination of
heteroplasmy of mtDNA, at a level of1%–2% (Suom-
alainen et al. 1993; Juvonen et al. 1994). In the present
study, we were able to detect heteroplasmy, at a level of
0.5% T (see fig. 1). In the initial screen, heteroplasmic
nucleotide variations were observed at 6 of the 288 sites
analyzed. The C309T variant was observed in three in-
dividuals, at levels of 80%, 3%, and 50%. C16093T
was seen in one individual (at a level of 28%) and
C16189T in another individual (at a level of 98%). In-
terestingly, one individual was heteroplasmic at both nt
309 (at a level of 3%) and nt 16189 (at a level of 97%)
(data not shown), indicating that one mitochondrial ge-
nome contains the 309C and 16189C variants and that
the other mitochondrial genome contains the 309T and
16189T variants.
For three of the women with detected heteroplasmy
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Figure 1 A, Minisequencing standard curves for determination
of the heteroplasmy levels of the C309T (red) and C16189T (blue)
variants of human mtDNA. The standard curves were prepared by
mixing plasmids containing sequence-verified cloned variant and nor-
mal mtDNA fragments in known proportions, followed by PCR with
a biotinylated primer and minisequencing primer extension in strep-
tavidin-coated microtiter-plate wells with [3H]dNTPs as label (Syva¨nen
et al. 1993). The ratio between the amount of [3H]dTTP and [3H]dCTP
incorporated into the minisequencing reaction is plotted as a function
of the ratio between the two sequence variants. Mean values, with
SDs (coefficient of variance !10%), are plotted. The signal ratios from
control samples containing only one of the sequence variants are given
on the vertical axes on the right. B, Fluctuation of heteroplasmy levels
of the C309T (red) and C16189T (blue) variants of mtDNA in cervical-
cell samples from four individuals during 9–25 years. Each data point
represents the mean values from three separate assays, with the in-
terassay range of variation indicated by the vertical line. Quadruplicate
samples of each PCR product were analyzed in each assay.
in their leukocyte samples, we were able to retrieve sev-
eral cervical-smear samples collected during 20–25
years. From a fourth woman, who was deceased and
had been affected by spinocerebellar ataxia type 7, we
obtained autopsy samples from 14 different tissues, in
addition to three cervical-cell samples taken during 9
years. DNA was extracted from the papanicolaou-
stained cell smears (Josefsson et al. 1999) from the four
women and from ∼100 mg of the tissue samples of the
deceased woman. mtDNA fragments spanning nt 309
and nt 16189 were amplified by PCR, from 200 ng of
DNA. C309T is a deletion of a C residue in a C homo-
polymer stretch (Bendall and Sykes 1995), and the first
nucleotide (a T residue) following the homopolymer
stretch is detected in the minisequencing reaction. The
relative amounts of the T and C sequence variants at nt
309 and nt 16189 were determined accurately by min-
isequencing-quantification standard curves, analyzed in
parallel (fig. 1a). The quantitative analysis demonstrated
that the level of heteroplasmy of the C309T and
C16189T variants remained unaltered in cervical cells
in all four individuals during the time studied (fig. 1b).
The autopsy tissue samples contained the C309T variant
in heteroplasmic form, at levels of 84%–91% (fig. 2).
Our longitudinal analysis, during 1 or 2 decades, of
four individuals with different levels of heteroplasmy in
the control region of mtDNA, combined with the data
from autopsy samples from several tissues of one of the
individuals, suggests that heteroplasmy in the mtDNA
control region is inherited and remains stable through-
out life, without selection for either of the variants. On
the basis of our study, heteroplasmy in themitochondrial
control region is rare and does not seem to be the result
of somatic accumulation of sequence variation, as has
been proposed elsewhere (Michikawa et al. 1999; Cal-
loway et al. 2000). Our findings are important and re-
assuring for forensic identity testing and human evolu-
tionary studies, which, so far, have been extensively
based on the analysis of polymorphic sequence variation
in the control region of mtDNA.
Figure 2 Heteroplasmy levels of the C309T variant of human
mtDNA in autopsy tissue samples from one individual. Mean values
of three separate assays are shown, and quadruplicate samples of each
PCR product were analyzed in each assay.
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